Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

A

AKTX

Akari Therapeutics Plc ADR

7.84

Nov 02 • 3:57 PM ET -0.40 (-4.85%)

7.84

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Nano NASD

Peers: PYXS STRO BCYC CTMX ZYME ALXO ADCT FHTX CGEN NVCT

Scroll to Statements

Index	-
Market Cap	13.72M
Enterprise Value	6.66M
Income	-30.90M
Sales	0.00M
Book/sh	10.62
Cash/sh	4.43
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.74
P/C	1.77
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.60
Current Ratio	0.60
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-17.25
EPS next Y	-5.49
EPS next Q	-2.23
EPS this Y	52.32%
EPS next Y	44.32%
EPS next 5Y	46.65%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	1.39%
Sales Q/Q	-
Earnings	Aug 13 AMC
EPS/Sales Surpr.	100.00% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	8.71%
Inst Trans	305.23%
ROA	-69.02%
ROE	-139.80%
ROIC	-166.16%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-6.89%
SMA50	-15.56%
SMA200	-13.33%
Trades

Shs Outstand	1.75M
Shs Float	1.74M
Short Float	1.01%
Short Ratio	0.28
Short Interest	0.02M
52W High	33.60 -76.67%
52W Low	3.02 160.03%
Volatility	13.29% 12.11%
ATR (14)	1.08
RSI (14)	44.71
Beta	1.47
Rel Volume	0.19
Avg Volume	62.12K
Volume	11,865

Perf Week	2.75%
Perf Month	-10.09%
Perf Quarter	0.64%
Perf Half Y	30.88%
Perf YTD	-32.18%
Perf Year	-73.87%
Perf 3Y	-94.46%
Perf 5Y	-99.41%
Perf 10Y	-99.89%
Recom	1.00
Target Price	25.50
Prev Close	8.24
Price	7.84
Change %	-4.85%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)